Friday, March 24, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

USAMRIID Contract for Shark Inoculation with Vaccinia Virus

by Global Biodefense Staff
January 7, 2013

Nurse SharkThe United States Army Medical Research of Infectious Disease (USAMRIID) Diagnostic Systems Division has awarded a sole source contract to the University of Maryland, Baltimore to inoculate sharks with recombinant vaccinia virus proteins.

The overall goal of the research is to create more rugged immunodiagnostic assays using single domain antibodies (sdAbs). While traditional antibody-based tests use canonical antibodies (cAbs), whose relative fragility requires a cold chain for storage and transportation, sdAbs have a much higher thermostability while maintaining comparable affinities and immunogenicity.

Sharks, llamas and other camelids are the only known species to produce such sdAbs.  Under the research award, sharks will be inoculated with recombinant vaccinia virus protein L1 to stimulate sdAb production against L1.

The contract includes a one-year base period with four twelve-month option periods. 

Related Resource: Design and testing of a thermostable platform for multimerization of single-domain antibodies (US Army RDECOM, August 2012 .pdf)

Tags: AwardsRuggedizedSmallpoxThermostabilityUSAMRIID

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC